Fully integrated first in human through proof of concept services

Better decisions faster

With a full scope of services from First in Human through Proof of Concept, PAREXEL's early phase operational teams are right where you need us. With a global network of clinical units testing compounds and devices in healthy volunteers and patients, we can help you make valuable decisions quickly and safely. PAREXEL Early Phase can help you make better decisions - faster. Our consistent delivery of timely results and high quality data adds value now - and greater value in the long term, providing expertise and advice to help you collect the right data and mitigate risk of Phase III failure.

Early phase services include

• First in Human
• Dose escalation (including long-stay studies)
• Clinical pharmacology
• PK/PD
• Disease modeling
• tQTc
• Ethno-bridging
• Bioequivalence/bioavailability
• Bioanalytical analysis
• Biomarker development and analysis
• Scientitific data services
• and many more tailored clinical development services to meet your specific needs

Healthy volunteers and 70+ patient populations

PAREXEL Early Phase understand the importance of rapid recruitment solutions in drug development. We have one of the largest global databases of healthy volunteers and over 70 diverse patient populations available in-house directly through our global network of clinical units.